Promazine
Back to searchMolecule Structure
Scientific Name
Promazine
Description of the Drug
Promazine is a phenothiazine used to manage schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00420
http://www.drugbank.ca/drugs/DB00420
Brand Name(s)
Not Available
Company Owner(s)
Hikma Pharmaceuticals Usa Inc, Watson Laboratories Inc, Wyeth Ayerst Laboratories
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL140489 | |
| PharmGKB | PA451126 | |
| Human Metabolome Database | HMDB0014564 | |
| DrugBank | DB00420 | |
| PubChem: Thomson Pharma | 14848900 | |
| PubChem | 4926 | |
| LINCS | LSM-2137 | |
| Nikkaji | J2.805C | |
| PDBe | P2Z | |
| BindingDB | 67545 | |
| EPA CompTox Dashboard | DTXSID2023517 | |
| DrugCentral | 2284 | |
| Brenda | 7491 | |
| ChemicalBook | CB5875452 | |
| Guide to Pharmacology | 7281 | |
| rxnorm | PROMAZINE HYDROCHLORIDE | PROMAZINE |
| KEGG Ligand | C07379 | |
| ChEBI | 8459 | |
| ZINC | ZINC000000010402 |
